Our laboratory has previously shown in a rhabdomyosarcoma animal model that targeting CXCR4 with a monoclonal antibody in combination with activated and expanded NK-cell therapy prevented lung metastasis and tumor implantation [82]. This evidence concerns the gene CXCR4 and neoplasm.